July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
Clinical and imaging outcomes of patients with retinal vasculitis
Author Affiliations & Notes
  • Salam Bachour
    Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, United States
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Parisa Emami Naeini
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Sumit Sharma
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Kimberly Baynes
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Arthi Venkat
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Careen Lowder
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Sunil K Srivastava
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Footnotes
    Commercial Relationships   Salam Bachour, None; Parisa Emami Naeini, None; Sumit Sharma, None; Kimberly Baynes, None; Arthi Venkat, None; Careen Lowder, None; Sunil Srivastava, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1710. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Salam Bachour, Parisa Emami Naeini, Sumit Sharma, Kimberly Baynes, Arthi Venkat, Careen Lowder, Sunil K Srivastava; Clinical and imaging outcomes of patients with retinal vasculitis. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1710. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the long term clinical outcomes in retinal vasculitis patients

Methods : This is an IRB approved retrospective study of retinal vasculitis patients seen at the Cole Eye Institute between the years of 2009-20018. Clinical outcomes were gathered from electronic medical records. Characteristics of patients included sex, age, clinical activity, associated systemic etiologies, and time of diagnosis. Outcomes for patients with minimum of 12 month follow up were analyzed. Outcomes included visual acuity, flares observed, number of injections, medications, and intraocular surgeries. Presence of complications including cystoid macular edema, epiretinal membrane, and steroid-induced glaucoma were also collected. Imaging modalities was also reviewed and analyzed.

Results : 261 eyes of 145 patients (88 females) were identified for this study. 117 patients presented with bilateral involvement. Average age at presentation was 45.7 years. Mean follow-up time was 41.3±25.6 months. At last visit, 27 patients (19%) had activity upon exam, and 49 cases were still considered idiopathic (34.02%). 96 patients had a confirmed systemic disease, of which, 49 were diagnosed after initial presentation. Top confirmed diagnoses included sarcoidosis (11.81%), behcet’s (8.33%), systemic lupus erythematosus (5.56%), and multiple sclerosis (5.56%). 200 eyes of 109 patients were included for outcome analysis. We observed a median of 0.5 [0.25,1.0] ophthalmic flares per eye years and 0.167 [0,0.5] injections per eye years. 88 patients (80%) required systemic immune suppression, 34 patients (31.2%) developed steroid induced glaucoma, 90 eyes (45%) developed cystoid macular edema (0.18 CME events per eye years) at one point of their disease course, and 51 eyes (25.5%) developed epiretinal membrane over course of disease. Mean logMAR visual acuity was 0.39 at presentation and 0.47 at 2-year follow up.

Conclusions : This study shows a high association between retinal vasculitis and a known systemic cause, with over half of the diagnoses made after initial clinical presentation. Systemic immune suppression was required in a large majority of patients, leading to excellent control of inflammation and relatively low number of flares per eye year—indicating its significant role in the management of this disease.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×